These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31035322)

  • 1. Single-Domain Antibodies Represent Novel Alternatives to Monoclonal Antibodies as Targeting Agents against the Human Papillomavirus 16 E6 Protein.
    Togtema M; Hussack G; Dayer G; Teghtmeyer MR; Raphael S; Tanha J; Zehbe I
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel intracellular nanobody against HPV16 E6 oncoprotein.
    Zhang W; Shan H; Jiang K; Huang W; Li S
    Clin Immunol; 2021 Apr; 225():108684. PubMed ID: 33549834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
    Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanobody against the E7 oncoprotein of human papillomavirus 16.
    Li S; Zhang W; Jiang K; Shan H; Shi M; Chen B; Hua Z
    Mol Immunol; 2019 May; 109():12-19. PubMed ID: 30849663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human papillomavirus antibodies in individuals with head and neck cancer.
    Lang Kuhs KA; Pawlita M; Gibson SP; Schmitt NC; Trivedi S; Argiris A; Kreimer AR; Ferris RL; Waterboer T
    Cancer Epidemiol; 2016 Jun; 42():46-52. PubMed ID: 27010729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
    Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
    J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targetting of the N-terminal domain of the human papillomavirus type 16 E6 oncoprotein with monomeric ScFvs blocks the E6-mediated degradation of cellular p53.
    Giovane C; Trave G; Briones A; Lutz Y; Wasylyk B; Weiss E
    J Mol Recognit; 1999; 12(2):141-52. PubMed ID: 10398405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular localization and quantitation of the human papillomavirus type 16 E6 oncoprotein through immunocytochemistry detection.
    Jackson R; Togtema M; Zehbe I
    Virology; 2013 Jan; 435(2):425-32. PubMed ID: 23084288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and Characterization of Antibodies in Single-Chain Format against the E6 Oncoprotein of Human Papillomavirus Type 16.
    Verachi F; Percario Z; Di Bonito P; Affabris E; Amici C; Accardi L
    Biomed Res Int; 2018; 2018():6583852. PubMed ID: 29888271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies.
    Wang JW; Jagu S; Wu WH; Viscidi RP; Macgregor-Das A; Fogel JM; Kwak K; Daayana S; Kitchener H; Stern PL; Gravitt PE; Trimble CL; Roden RB
    Clin Vaccine Immunol; 2015 Jul; 22(7):806-16. PubMed ID: 25972404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression, purification, and serum antibody detection of HPV16 E6 in cervical cancer patients].
    Gao YE; Guo JZ; Zhang J; Song TB; Yan XJ
    Ai Zheng; 2006 Nov; 25(11):1374-9. PubMed ID: 17094904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers.
    Reuschenbach M; Waterboer T; Wallin KL; Einenkel J; Dillner J; Hamsikova E; Eschenbach D; Zimmer H; Heilig B; Kopitz J; Pawlita M; Doeberitz Mv; Wentzensen N
    Int J Cancer; 2008 Dec; 123(11):2626-31. PubMed ID: 18785210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
    Gambhira R; Gravitt PE; Bossis I; Stern PL; Viscidi RP; Roden RB
    Cancer Res; 2006 Dec; 66(23):11120-4. PubMed ID: 17145854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Human Papillomavirus-Associated Cancer by Oncoprotein-Specific Recombinant Antibodies.
    Donà MG; Di Bonito P; Chiantore MV; Amici C; Accardi L
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and Characterization of Single-Domain Antibodies from Immune Phage Display Libraries.
    Rossotti MA; Trempe F; van Faassen H; Hussack G; Arbabi-Ghahroudi M
    Methods Mol Biol; 2023; 2702():107-147. PubMed ID: 37679618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.
    Hasan UA; Bates E; Takeshita F; Biliato A; Accardi R; Bouvard V; Mansour M; Vincent I; Gissmann L; Iftner T; Sideri M; Stubenrauch F; Tommasino M
    J Immunol; 2007 Mar; 178(5):3186-97. PubMed ID: 17312167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A magnetic immunochromatographic strip test for detection of human papillomavirus 16 E6.
    Peck RB; Schweizer J; Weigl BH; Somoza C; Silver J; Sellors JW; Lu PS
    Clin Chem; 2006 Nov; 52(11):2170-2. PubMed ID: 18084827
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.
    Kenter GG; Welters MJ; Valentijn AR; Lowik MJ; Berends-van der Meer DM; Vloon AP; Drijfhout JW; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; van der Burg SH; Melief CJ
    Clin Cancer Res; 2008 Jan; 14(1):169-77. PubMed ID: 18172268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccine against human papillomavirus type 16: modifications of the E6 oncogene.
    Poláková I; Pokorná D; Dusková M; Smahel M
    Vaccine; 2010 Feb; 28(6):1506-13. PubMed ID: 20003917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of antibodies in single-chain format against the E7 oncoprotein of the human papillomavirus type 16 and their improvement by mutagenesis.
    Donà MG; Giorgi C; Accardi L
    BMC Cancer; 2007 Jan; 7():25. PubMed ID: 17266749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.